Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | ATM | Q13315 | 2/20 | 0.43 |
| ▸ | RCE1 | Q9Y256 | 2/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.43 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.43 |
| ▸ | HPGD | P15428 | 3/20 | 0.42 |
| ▸ | NPC1 | O15118 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 3/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.40 |
| ▸ | TP53 | P04637 | 2/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12799824 | 0.96 | ALOX5 (0.47) | MEN1KMT2AATMRCE1L3MBTL1 | |
| SCHEMBL12968431 | 0.94 | ALOX5 (0.46) | MEN1KMT2AATMRCE1L3MBTL1 | |
| SCHEMBL12968447 | 0.91 | ALOX5 (0.46) | MEN1KMT2AATMRCE1L3MBTL1 | |
| SCHEMBL12969344 | 0.91 | ALOX5 (0.46) | MEN1KMT2AATMRCE1L3MBTL1 | |
| SCHEMBL17228738 | 0.89 | MAPT (0.42) | L3MBTL1HPGDNPC1TSHRRAB9A | |
| SCHEMBL12799862 | 0.88 | MAPT (0.44) | MEN1KMT2AATMRCE1L3MBTL1 | |
| SCHEMBL12799828 | 0.88 | MAPT (0.44) | MEN1KMT2AATMRCE1L3MBTL1 | |
| SCHEMBL12968523 | 0.88 | KDM4E (0.44) | MEN1KMT2AL3MBTL1ALOX5HPGD | |
| SCHEMBL25808391 | 0.88 | NR1I3 (0.43) | MEN1KMT2AL3MBTL1ALOX5HPGD | |
| SCHEMBL17625273 | 0.87 | MAPT (0.42) | L3MBTL1ALOX5HPGDNPC1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10431750-B2 | 4H-imidazo[1,2-a]imidazoles for electronic applications | UDC IRELAND LIMITED (IE) | 2019-10-01 | — | — | US | disclosed |
| US-20190273211-A1 | 4H-Imidazo[1,2-a]imidazoles for Electronic Applications | UDC IRELAND LTD (IE) | 2019-09-05 | — | — | US | disclosed |
| US-9806270-B2 | 4H-imidazo[1,2-a]imidazoles for electronic applications | UDC IRELAND LIMITED (IE) | 2017-10-31 | — | — | US | disclosed |
| EP-3034508-A1 | 4H-IMIDAZO[1,2-A]IMIDAZOLES FOR ELECTRONIC APPLICATIONS | BASF SE (DE) | 2016-06-22 | — | — | EP | disclosed |
| EP-2688889-B1 | 4H-IMIDAZO[1,2-A]IMIDAZOLES FOR ELECTRONIC APPLICATIONS | BASF SE (DE) | 2016-05-18 | — | — | EP | disclosed |
| WO-2012130709-A1 | 4H-IMIDAZO[1,2-A]IMIDAZOLES FOR ELECTRONIC APPLICATIONS | BASF SE (DE) | 2012-10-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10431750-B2 | 4H-imidazo[1,2-a]imidazoles for electronic applications | EIF4A1, ITPR2, ITPR1 | MEN1 1068/4885KMT2A 811/4885ATM 3638/4885 |
| US-20190273211-A1 | 4H-Imidazo[1,2-a]imidazoles for Electronic Applications | PAH, NISCH, KCNH1 | MEN1 1115/4885KMT2A 756/4885ATM 3506/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.